Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 45
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Targeted Drug Delivery by using Magnetic Nanoparticles

    What if we could use a novel approach for delivering currently injectable drugs to the body without syringes...

    T Cell Vaccines as an Immunotherapy for Type 1 Diabetes

    Type 1 Diabetes develops when CD4+ T cells aren't taught to differentiate between self-antigens and foreign...

    Can cockroaches help us cure tularemia?

    Tularemia is a deadly disease caused by the bacterium Francisella tularensis (Ft). This bacterium is also a...

    Backer Badge Funded